HomeElementElement Co-Authors Peer Reviewed Journal in Collaboration with the FDA

Element Co-Authors Peer Reviewed Journal in Collaboration with the FDA

Element Materials Technology (Element), one of the world’s leading providers of testing, inspection and certification services to the international medical device sector, has co-authored a peer-reviewed journal article in collaboration with the U.S. Food and Drug Administration (FDA).

Element has developed a method of assessing nickel ion release from nitinol stents that have been fatigue loaded to mimic physiologically-relevant conditions. A collaboration with the FDA was initiated to jointly study whether fatigue loading accelerates nickel ion release.

Published in the Shape Memory and Superelasticity, Advances in Science and Technology journal by Springer, the article titled “The Impact of Fatigue Testing and Surface Processing on Nickel Release in Nitinol Stents” summarizes the findings which highlight the impact of fatigue loading on uniform corrosion for different nitinol stent surfaces.

Rick Sluiters, EVP Aerospace, commented: “We are delighted to work with the FDA on this important study of better understanding the impact of fatigue loading on nickel release from nitinol stents.

“As a global leader in medical device testing, we will continue to deepen our expertise and develop collaborations that advance knowledge and bring safe devices to the market.”

Element’s medical device laboratories, located in the Americas and Europe, provide a comprehensive range of mechanical testing and product qualification testing on hip, knee & spinal implants; trauma devices; cardiovascular & orthopaedic devices, and implantable, diagnostic and therapeutic equipment. Element offers consulting and testing services in prototype development, polymer synthesis and materials selection, coatings and adhesives, 510(k) and CE submissions and a wide range of failure and contaminant investigation capabilities.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy